Literature DB >> 30174325

Safe administration of rituximab in patients with chronic lymphocytic leukemia and a history of obinutuzumab‑associated anaphylaxis.

Aleksander Salomon-Perzyński, Agnieszka Końska, Daria Zawirska, Ewa Lech-Marańda, Krzysztof Jamroziak.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30174325     DOI: 10.20452/pamw.4327

Source DB:  PubMed          Journal:  Pol Arch Intern Med        ISSN: 0032-3772


× No keyword cloud information.
  1 in total

1.  Type I allergic reaction to rituximab upon first lifetime exposure: a case report.

Authors:  V Polito; A Barbacki; G Isabwe
Journal:  Allergy Asthma Clin Immunol       Date:  2020-06-26       Impact factor: 3.406

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.